Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
News published by Santhera Pharmaceuticals concerning POL6014 in cystic fibrosis, administered with an optimized investigational eFlow® Technology nebulizer.